Arcturus Therapeutics Inc - ARCT Net earnings per one share for the last twelve months

Arcturus Therapeutics Inc (ARCT) - corporate logo

Arcturus Therapeutics profitability is based on the expansion of mRNA therapy within the rare disease segment. On the GURU.Markets platform, the annual EPS (TTM) change indicator demonstrates profit dynamics, where -25.30 reflects the latest value of the metric. Self-amplifying mRNA technology enhances the safety of liver treatment, while R&D development is fully funded through strategic licensing agreements with global pharma behemoths.

ARCT: arcturusrx.com Net earnings per share for the last 12 months 02/11/2024 - 11/17/2026

Arcturus Therapeutics - analytical breakdowns and key metrics (ARCT)

Fundamental company valuation:ARCT - Arcturus Therapeutics Inc
Brand item of Arcturus Corp

This metric measures the year-over-year dynamics of net income per share, reflecting the efficiency of business capitalization and the ability to generate income net of the cost of attracted resources. By analyzing the relative change chart of EPS YoY TTM, investors assess the monetization potential of the Arcturus Therapeutics (ARCT) R&D pipeline amid the market launch of mRNA products and the preparation of cystic fibrosis therapy.

Competitor analysis

Earnings per one share for the last 12 months VRTX|ALNY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insmed Inc (INSM)|UTHR (United Therapeutics Corporation) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BMRN (BioMarin)|Net earnings per share for the last 12 months BBIO (BridgeBio)|BGM: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Earnings per one share for the last 12 months|Keros Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ETON (Eton Pharmaceuticals)|KMDA: Net earnings per share (EPS TTM)|Fulcrum Therapeutics Inc (FULC) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months abeonatherapeutics.com|MREO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PLX|Net earnings per share for the last 12 months Pliant Therapeutics, Inc. PLRX|Net earnings per share (EPS TTM) APLT (Applied Therapeutics Inc.)|Net earnings per share (EPS TTM) Rein Therapeutics Inc. RNTX|gelteq.com - Net earnings per share (EPS TTM)|AYTU - Net earnings per share (EPS TTM)|CMMB: Net earnings per share (EPS TTM)|SRx Health Solutions Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Polyrizon Ltd|AEZS (Aeterna Zentaris) - Earnings per share for the last four quarters|Earnings per share for the last twelve months CTD Holdings (CYTH)|INZY: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Reneo Pharmaceuticals Inc. RPHM|Net earnings per share for the last four quarters COSCIENS Biopharma Inc. (CSCI)